Genomic-based Tools To Support The Control Of Urogenital Schistosomiasis And Hepatic Opisthorchiasis
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Over 100 million people are affected by parasitic flukes that promote malignant tumours. Parasite control depends on a single drug, making resistance an imminent threat. I will deliver new genomic tools to unravel the complex interactions between parasites and humans, and explore parasite population diversity on a continental scale. I will then prioritise a panel of anti-parasitic drug targets and vaccine candidates to deliver the next generation of interventions against parasitic diseases.
Schistosomiasis is a disease caused by parasites known as schistosomes. As the current use of a single drug could lead to resistance, there is an urgency for new drugs. I discovered a novel cell death machinery in schistosomes and I now aim to unravel how this cell death pathway works and to identify the players required for parasite survival. The next step will then be to develop molecules that neutralize the activity of these pro-survival molecules hence leading to parasite death.
Sustainable Control And Elimination Of Neglected Tropical Diseases In The Asia-Pacific
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
The neglected tropical diseases (NTDs) are of major public health importance. Parasitic worms are the most common infecting almost a third of the world’s population. Multi-component integrated intervention strategies will be required for sustainable control and elimination of NTDs in the Asia-Pacific. I will develop and lead the first Australian Centre for Population Health Research on NTDs that will undertake research into their epidemiology, control and elimination.